Introduction
Long-term survival after lung transplantation (LTx) is hampered by chronic lung allograft dysfunction (CLAD) which is believed to reflect chronic rejection (1) . With one of the highest rejection rates amongst all solid organ transplantations, approximately 50% of LTx recipients suffer from CLAD within five years after transplantation (2) . Phenotypes of CLAD with different clinical characteristics and prognoses have been reported in the literature. The most common being bronchiolitis obliterans syndrome (BOS), characterized by an obstructive pulmonary function defect, obliterative bronchiolitis (OB) on histopathologic examination and air trapping and mosaic attenuation on imaging. As a result of the complex pathophysiology of these CLAD phenotypes, treating physicians often face difficulties to obtain an exact and early diagnosis
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The gold standard for BOS diagnosis continues to be monitoring of lung function, which is easy to use, cost-effective and provides sufficient repeatability. Lung imaging, primarily via computed tomography (CT), is commonly used to complement spirometry for BOS diagnosis. In BOS, air trapping is visually identified on end-expiration CT scans as parenchymal areas with low attenuation and lack of volume reduction. De Jong and colleagues proposed a composite CT score for BOS diagnosis, comprised of bronchiectasis, mucus plugging, airway wall thickening, consolidation, mosaic pattern and air trapping (AT), which was associated with forced expiratory volume in 1 second (FEV 1 Quantitative CT-based analytical measures have shown promise in improving disease diagnosis, phenotypes and prognosis, as well as providing 3D visualization of the disease extent.
Parametric response mapping (PRM), a quantitative imaging processing technique applied to inspiration and expiration CT scans was shown to quantify the extent of parenchyma with emphysematous AT and non-emphysematous AT, which is referred to as functional small airways disease (fSAD) in a cohort of COPD patients (4) . In a retrospective study of hematopoietic stem cell recipients, PRM was found to be a strong readout of BOS even in the presence of infection (5) .
Although serial PRM measurements were obtained in only one subject, this technique showed promise in monitoring BOS progression. Here we evaluated PRM as a readout of BOS diagnosis and progression in LTx recipients. ) (3) . Although this scoring system showed good reproducibility, this is a semi-quantitative technique that requires experienced readers for accurate and repeatable scoring.
Material and methods

Patient population
Serial paired CT scans were obtained from LTx recipients diagnosed with BOS (n=20) and recipients without CLAD (n=20) as part of a single site retrospective study. Included patients were all double LTx recipients; and both groups were matched for post-operative day of CT, native lung disease, age and gender. All patients have reached a best post-operative FEV 1 >80% predicted and all BOS patients received azithromycin treatment for BOS but were found to be non-responsive. All BOS patients experienced a persistent FEV 1 decrease >20% compared to the mean of the two best post-operative FEV 1 values without a concomitant decrease in TLC ≥10% (thus excluding rCLAD) . Inspiratory and expiratory CT scans from BOS recipients were acquired 3 months to 1 year before BOS, T pre , at time of BOS diagnosis, T 0 , and at the last available CT, T post , which may have occurred at end of follow-up, last CT prior to a second LTx or death. Time matched CT scans were obtained for the stable
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Computed Tomography
CT data were obtained as whole lung volumetric CT scans at full inspiration (TLC) and incremental scans at relaxed expiration (functional residual capacity) on Siemens Somatom scanner and reconstructed using a b60 or b70 reconstruction kernel. Slice thicknesses were 1.25 mm for all scans, with slice numbers on average around 220 for inspiration scans and 15 for expiration scans. All CT scans were checked for Hounsfield unit (HU) drift and if necessary corrected based on aortic blood (50 HU) and central air (-1000 HU) as previously described (6) .
Parametric Response Map
PRM was applied to all paired CT scans from both study groups. Briefly, lungs from both paired CT scans were segmented from the thoracic cavity using an in-house algorithm written in Matlab (The MathWorks, Inc. Natick, MA, USA). The whole-lung CT inspiration scan was spatially registered and aligned to the incremental CT scan obtained at expiration using Elastix, an open source image registration algorithm (7, 8) . Once complete, the images share the same geometric space where each voxel, the smallest unit of volume in a 3D image dataset, consists of HU values at inspiration and expiration. To minimize the effects of noise on the PRM analysis an adaptive noise-removal filter was applied to both spatially aligned CT scans. Individual voxels were then classified based on predetermined thresholds as normal (green), fSAD (yellow), emphysema (red) and parenchymal disease (purple). Voxels with values ≥-950 HU and <-810 HU at inspiration and ≥-856 HU at expiration were classified normal, ≥ -950 HU and <-810 HU at inspiration and <-856 at expiration were fSAD, <-950 HU at inspiration and <-856 HU at expiration were emphysema and ≥ -810 HU at inspiration were parenchymal disease, PD (5) . The emphysema and air trapping thresholds (-950HU and -856HU, respectively) have been previously defined and are used for CT analysis in the COPDGene clinical trial (9) (10) (11) (12) . The upper limit on the inspiratory CT (-810HU) was determined using healthy smokers accrued as part of the NORM trial (5, 13) . Global PRM measures were presented as relative lung volumes. The relative volumes for each classification are defined as the sum of all voxels within a class normalized to the sum of all voxels within the volume of the expiratory lungs multiplied by 100. 
Author Manuscript
This article is protected by copyright. All rights reserved immediately prior to a redo LTx. The lung specimen was collected and scanned using an adapted protocol of our previous work (14, 15 ) (online supplement 1).
Statistical Analysis
All results are shown as median (interquartile range). Differences in continuous variables between BOS and stable patients were determined using a student's T-test. A contingency test was used to assess group difference in discrete data. Paired t-test was used to assess differences between time points (i.e. T pre , T 0 and T post ). In addition to the absolute values determined by PRM, the relative change in PRM Normal and PRM fSAD were evaluated between time points and groups. The relative change in PRM metric is defined as 100*[PRM i (T j )-PRM i (T pre )]/PRM i (T pre ), where i is an index to denote normal and fSAD and j denotes time points (T 0 , T post ). Spearman-rank test was performed for correlation analysis between the relative change in pulmonary function measurements and PRM fSAD .
ROC analysis was performed to estimate the specificity and sensitivity of rPRM fSAD at T 0 to detect BOS using the entire study population (n=40). All tests were performed using graph pad prism 6.0 (GraphPad Software, Inc. La Jolla, CA, USA).
Results
Study population
Patient characteristics are presented in table 1. Patients were selected to minimize potentially confounding effects as well as to time-match post-operative CT acquisitions. As such, no significant differences in age, underlying disease, gender and post-operative day of CT scanning between the BOS and stable groups were observed. At T pre , 9 patients from the BOS group had BOS0p versus 5 in the stable group. Four patients in the stable group had BOS0p at T 0 which increased to 9 patients at T post . However none of the stable patients reached BOS1 at any timepoint.
Serial examination of PRM measurements
Representative PRM slices from two cases are shown in Figure 1 . Population results for serial PRM fSAD and PRM Normal measurements are shown in Figure 2A and 2B. BOS patients demonstrated a significant increase in PRM fSAD from T pre (18±3%) to T 0 (33±4%; p=0.006). Although the moderate increase in PRM fSAD from T 0 to T post (45±6%) was not significant (p=0.18), PRM fSAD at T post was found to be significant higher compared to T pre values (p<0.0001). In stable patients, a negligible variation in PRM fSAD was observed from T pre to T 0 and T post (p=0.27 and p=0.28 respectively). PRM Normal decreased
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Group Comparisons
).
Negligible group differences were observed in PRM values of fSAD and healthy parenchyma (p=0.17 and p=0.14, respectively; Figure 2A and B) and FEV 1 (p=0.14; Table 1 ) at T pre . Interestingly, the mean values for PRM fSAD at T pre were slightly higher in both groups (BOS and stable had 18±3% and 24±4%, respectively) compared to a previously described healthy (non-transplant) control groups (<10% (4) and <15%, supplement material (5)). Although PRM fSAD was higher at T 0 for BOS patients than stable patients, these values were not significant (p=0.09; Figure 2A ). The steady increase in PRM fSAD in BOS patients resulted in a significant difference between BOS and stable patients at T post (p=0.0002). Similarly, PRM Normal were significantly lower at T 0 (p=0.02) and T post (p=0.04) in BOS patients when compared to stable patients ( Figure 2B ). To evaluate if PRM fSAD can detect BOS severity, patients diagnosed with BOS were separated based on BOS grade. Results from this analysis found that patients with BOS 2-3 (n=7) at diagnosis had three times more PRM fSAD (26±7%) than BOS 1 patients (n=13; 9±7%). Although this result was not found to be significant (p=0. Figure 2C -D. As shown in Figure 2C , patients diagnosed with BOS were found to have a relative increase in PRM fSAD of 422±127% at T 0 (p=0.005) and 436±95% at T post . These values were significantly higher than rPRM fSAD observed in stable patients (rPRM fSAD at T 0 of 92±16% (p=0.004) and at T post 116±30% (p=0.001). Presented in Figure 2D , rPRM Normal was found to be lower in BOS patients as compared to stable patients. These values were significantly different between groups at T 0 (p=0.004), but lost significance by T post (p=0.07). The extent of change in rPRM Normal was only significant at T post for BOS patients (p=0.009). By ROC analysis, the relative increase in PRM fSAD at T 0 was found to be significantly associated with BOS (p=0.005). An optimal cutoff of rPRM fSAD at T 0 was found to be 173%, which had 62.5% sensitivity and 93.8% specificity to predict BOS development.
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Confirmation by microCT
Presented in Figure 4 are PRM and microCT results from a representative BOS explant specimen. Using CT scans acquired at T post , this patient was found to have PRM measures over both lungs of 15% for healthy parenchyma, 56% for fSAD, 19% for PD and 4% for emphysema. As seen in Figure 4A and B, the PRM, with corresponding scatter plot, at the exact location of the selected core showed a high percentage of fSAD (PRM fSAD =67%) with lower values in PD (PRM PD =16%), normal parenchyma (PRM Normal =9%) and emphysema (PRM Emph =1%). MicroCT confirmed the presence of small airway obliteration on 2 separate locations within the single scanned specimen ( Figure 4C and D) which is compatible with obliterative bronchiolitis, the pathological correlate of BOS.
Discussion
In this manuscript, we demonstrated the potential value of serial radiological PRM measurements in diagnosing and monitoring BOS. We provided further support for our findings by demonstrating a correlation between PRM fSAD and FEV 1 An interesting find in this study was the elevated PRM . Lastly, microCT examination confirmed the presence of small airway obliteration, explaining the fSAD documented with the PRM measurement. fSAD observed in all LTx recipients prior to any pulmonary function defect. These values were higher than observed from non-transplant healthy smokers reported in the literature (4, 5) . Although all patients in this study had a FEV 1 >80% predicted at T pre , this find corroborates the observation that air trapping occurs early after LTx, even in stable patients. This is thought to be attributed by some degree of small airway disease secondary
Author Manuscript
This article is protected by copyright. All rights reserved to the transplantation procedure (16) . Also, more extended criteria donors, typically older with a longer smoking history, are more commonly used (17) . (18) .
Recently, Solyanik et al compared 3 methods of quantifying air trapping in LTx patients
Their approach differed from the present study in that multiple measurements within the same patients were not obtained. Nevertheless, one method applied a density mapping approach with voxel-to-voxel comparison of inspiratory and expiratory CT analogous to PRM, with the difference being the use of a single threshold applied to the expiratory CT scan. The authors demonstrated a correlation with residual volume/total lung capacity (used to define pathologic air trapping) and the density mapping technique. In parallel, we also quantified air trapping by radiological scoring and compared this to PRM (online supplement 2). Although air trapping progressively increased in BOS patients, we were unable to demonstrate a correlation between FEV 1 Interestingly, in end-stage BOS lungs 59% of the lung was found to be fSAD by PRM. This find corresponds well with the previously observed percentage of obstructed airways we calculated using our previously reported ex-vivo CT analysis of explanted lungs where we found that between 50 and 60% of the airways were obliterated from generation 7 on (14) . PRM decrease and increase in air trapping, demonstrating that PRM might be a more sensitive and objective measurement for estimating small airway obstruction compared to subjective scoring as PRM is probably better in detecting subtle differences in air trapping. fSAD The objective of this study was to evaluate PRM as an indicator of BOS progression. As such patients with rCLAD were deliberately excluded as they demonstrate elevated attenuation on inspiration CT scans as a result of central and peripheral ground glass opacities (19-21), since PRM has not been validated yet in restrictive lung disease, these patients were not further investigated. generated from the core (67%) slightly differed from what was calculated over the both lungs (56%). This is most likely attributed to spatial heterogeneity of the disease within the lungs. Therefore, severe airway obstruction observed in the analyzed lung strengthens the utility of PRM as a viable tool for monitoring BOS progression.
Other possible limitations include the relative low number of patients included in this study, which complicates analyses that require further group stratification. PRM is a quantitative densitybased CT technique that applies thresholds for sorting individual voxels into specific classifications.
As such various sources of variability may alter the density measurements effecting PRM classifications. In our previous work, we evaluated the effect these sources have on altering the PRM measurements (22). The limitations and generalizability of PRM is further discussed in online supplement 3. However, all CT scans in this study design were quality controlled by assessing HU drift
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This article is protected by copyright. All rights reserved and corrected when needed. In an effort to reduce the effects of variation in CT acquisitions and reconstruction kernels, a noise-reducing filter was applied to all scans prior to PRM analysis. It is possible that the PRM thresholds used may not fully represent disease state of the studied patient population. PRM fSAD was found to be elevated in pre-BOS recipients relative to healthy smokers, which was consistent to observations from a previous study (5) . This may be a consequence of the expiratory threshold (i.e. -856HU) over-estimating the extent of air trapping in the lungs.
Confirmation of PRM fSAD by microCT analysis of explanted lungs alleviates some of these possible concerns as OB lesions were observed in regions with high PRM fSAD . The big advantage of our study is the serial measurements from a stable to a diseased state (BOS), which is, to the best of our knowledge, not been performed in this context. It is well understood that spirometric decline is a hallmark of the onset of BOS. Yet clinical practice dictates that CT scans must be used to rule out other pulmonary complications that cause a decline in pulmonary function and to potentially differentiate with rCLAD. As CT scans are part of standard clinical management of these patients, PRM analysis of these scans may complement FEV 1 as an objective readout of the presence and extent of OB as indicated by PRM fSAD and might be specifically useful in patients where spirometry is difficult to interpret such as suture problems, pneumonectomy or single lung transplanted patients (see online supplement 4 for a representative example of a patient with fluctuating FEV 1 but stable
PRM fSAD
In conclusion, we demonstrate that PRM served as an imaging readout of BOS. Further proof of its applicability is provided by the correlation with spirometry and the presence of OB with microCT. PRM investigation may serve as a complementary tool to aid treating physicians in diagnosing BOS. Further research in this field would include a large, multi-center prospective trial and inclusion of patients with restrictive CLAD. These steps could further confirm the potential use and benefit of PRM for monitoring CLAD progression in LTx recipients. values).
Disclosure
The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. CJG and BDR have a financial interest in the underlying patented University of Michigan technology licensed to Imbio, LLC., a company in which BDR has a financial interest. The other authors have no conflicts of interest to disclose. PRM Normal obtained at T pre , T 0 and T post. Significant differences between timepoints for the BOS groups is denoted as * for p<0.05, ** for p<0.01, *** for p<0.001. Significant differences between
Figure legends
Author Manuscript
This article is protected by copyright. All rights reserved groups is denoted as # for p<0.05, ## for p<0.01, ### for p<0.001. Data is presented as the mean ± standard error of the mean. PRM, parametric response mapping. 
This article is protected by copyright. All rights reserved Author Manuscript This article is protected by copyright. All rights reserved 
